『The MedTech Step-Up Webinar』のカバーアート

The MedTech Step-Up Webinar

The MedTech Step-Up Webinar

著者: Lifeblood.com
無料で聴く

このコンテンツについて

Welcome to Lifeblood’s MedTech Step-Up Webinar where our aim is to make you venture backable.

At Lifeblood, we understand that transforming a groundbreaking medical innovation into a venture-backable company requires more than just a great idea—it demands the right strategic approach, team, and industry insight . Lifeblood

Our Step-Up Program is designed to bridge the gap between innovation and investment readiness. We provide early-stage MedTech companies with a comprehensive, founder-first roadmap, addressing critical legal, business and financial advisory, team building, and marketing strategies. Lifeblood

Through tactical, step-by-step guidance, we aim to equip you with the tools and insights necessary to attract serious capital and achieve long-term growth. Lifeblood

We’re excited to embark on this journey with you, turning your MedTech innovation into a thriving, industry-changing reality.

This is the MedTech Step-Up Program.

© 2025 The MedTech Step-Up Webinar
アート
エピソード
  • #7 -The Atomic Program: From Vision To Venture - Joseph Snyder and Cristiano Fontana
    2025/10/13

    Hosts:

    Joseph Snyder

    Head of Talent and Co-Founder, Lifeblood

    https://www.linkedin.com/in/josephasnyder1/

    Cristiano Fontana

    Head of Advisory, Lifeblood

    https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/

    Guests:

    Kavita Bouknight

    CEO, Match Health Collective

    Kavita Bouknight is the CEO of Match Health Collective which specializes in MedTech marketing, messaging, and design. Their work focuses on building compelling brand identities, developing cohesive visual design, crafting strategic messaging frameworks, and creating pitch-ready content and go-to-market strategies to drive visibility and accelerate adoption.

    https://www.linkedin.com/in/kavitabouknight/

    Martin Gomez

    Partner, Goodwin

    Co-leading the MedTech and Artificial Intelligence practice across IP, company formation, licensing, fundraising, an strategic transactions or exits.

    From FDA expectations to real-world applications, we explore what’s hype, what’s real, and what founders need to know to integrate AI responsibly. Tune in as they explore how AI is shaping product development, regulatory hurdles, and investor expectations across the MedTech landscape.

    https://www.linkedin.com/in/martin-gomez-898556113/

    続きを読む 一部表示
    1 時間 5 分
  • #6 - Beyond the Hype: Real AI Strategy for MedTech Startups - Joseph Snyder & Cristiano Fontana
    2025/08/10

    Hosts:

    Joseph Snyder

    Head of Talent and Co-Founder, Lifeblood


    https://www.linkedin.com/in/josephasnyder1/


    Cristiano Fontana

    Head of Advisory, Lifeblood

    https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/

    Guests:

    Darcy Bachert

    CEO, Prolucid

    Darcy Bachert is the Founder and CEO of Prolucid, an ISO-13485 certified software engineering firm that specializes in custom medical software development. Over the past 17 years Darcy has grown Prolucid to a team of 25, supporting innovative MedTech companies across the world in successfully bringing their applications and devices to market

    https://www.linkedin.com/in/darcybachert/

    Robert Hamilton

    CEO, NeuraSignal Inc.

    Robert is a seasoned healthcare entrepreneur, executive, and engineer with a deep commitment to driving transformative innovation in medicine. With a passion for aligning bold vision with high-performing teams, he has spent his career tackling some of the most complex challenges in healthcare.

    Robert’s vision and leadership continue to place NeuraSignal at the forefront of AI-powered neurodiagnostics, advancing the future of brain health.

    https://www.linkedin.com/in/hamiltonrobert/

    Carmen Brown

    Senior Manager of Regulatory Affairs, Proxima

    Carmen Brown is a Senior Regulatory Affairs Manager at Proxima Clinical Research, Inc. with 10 years of work experience in the pharmaceutical and medical device industry. Carmen has a master’s in public health and a bachelor’s degree in chemistry. At Proxima, Carmen has worked on both drug products and medical devices specializing in combination products. Her expertise spans a wide variety of therapeutic areas including oncology and IVDs that have included AI/ML.

    https://www.linkedin.com/in/carmen-brown-068462a6/

    続きを読む 一部表示
    1 時間 4 分
  • #5 - Will AI Make or Break Your MedTech Startup? - Joseph Snyder & Cristiano Fontana
    2025/07/27

    Hosts:

    Joseph Snyder

    Head of Talent and Co-Founder, Lifeblood


    https://www.linkedin.com/in/josephasnyder1/


    Cristiano Fontana

    Head of Advisory, Lifeblood

    https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/

    Guests:

    Darcy Bachert

    CEO, Prolucid

    Darcy Bachert is the Founder and CEO of Prolucid, an ISO-13485 certified software engineering firm that specializes in custom medical software development. Over the past 17 years Darcy has grown Prolucid to a team of 25, supporting innovative MedTech companies across the world in successfully bringing their applications and devices to market

    https://www.linkedin.com/in/darcybachert/

    Alex Condon

    COO, Matrix One

    Alex Condon is the former co-founder of Galen Data, a globally compliant medical device cloud platform that provides connectivity, centralizes data, and provides analytics for the next generation of medical device companies, acquired by Matrix one.

    https://www.linkedin.com/in/alexcondon/

    Marty Gomez

    Partner, Goodwin

    Marty Gomez co-leads the MedTech and Artificial Intelligence practice at Goodwin across IP, company formation, licensing, fundraising, an strategic transactions or exits.

    https://www.linkedin.com/in/martin-gomez-898556113/

    続きを読む 一部表示
    58 分
まだレビューはありません